Monday, August 24, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
RegulatoryAbbVie Launches Phase 2 Forehead Lines StudytodayMarketFacial Rejuvenation Market Forecast to Hit $5.66B by 20302 days agoBusiness & M&AAllergan Aesthetics Overhauls Loyalty ProgramtodayDevices & TechXERF Technology Enters Australian Market for Skin Tightening2 days agoBusiness & M&AEvolus Expands Estyme to Canada, Australia, New ZealandtodayMarketArm Fat Now Top Body Sculpting Concern in Singapore2 days agoDevices & TechSofwave Hits One Million Treatments MilestonetodayRegulatoryCKD Bio Pursues China Botox Approval—2027 Launch Targeted2 days agoRegulatoryRevance Wins FDA Nod for Under-Eye InjectablesyesterdayMarketGLP-1 Pill Era Is Forcing Beauty Market ShiftyesterdayInjectablesAEON Releases Expanded ABP-450 Botox Biosimilar DatayesterdayDevices & TechUltherapy PRIME Real-Time Imaging Reshapes Midface Liftingyesterday
Markets & Filings

13F

The quarterly filing revealing what large institutions bought and sold, a lagging window into smart money.

Also known as: Form 13F, Institutional Holdings

What it is
A 13F is a quarterly report that institutional managers overseeing at least the SEC threshold in assets must file, disclosing their U.S. equity long positions. It is due within 45 days of quarter end. It reveals holdings, not shorts or timing.
What it does
13Fs let investors track what prominent funds accumulated or dumped, informing conviction and crowding assessments. New positions can spark momentum when disclosed. It is a research input, not a real-time signal.
The evidence
Disclosure of a marquee fund initiating a large stake has repeatedly triggered follow-on buying in the named stock.
Best for
Any liquid U.S. equity followed by institutions.
Pairs well with
form-4, 8-k, thematic-etf
Use cautiously with
The data is up to 45 days stale and omits shorts and options context, so blindly copying it can be dangerous.
Cautions
Positions may already be exited by the time you read the filing.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

More markets & filings

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo →